UC San Diego researchers use experimental artificial intelligence system called DrugCell to predict the best approach to treating cancer. Only 4 percent of all cancer therapeutic drugs under development earn final approval by the U.S. Food and Drug Administration (FDA).
In a recent study, researchers at University of California San Diego School of Medicine found a seventh component of wisdom: spirituality.
Supercomputer simulations, done using resources at UC San Diego by researchers at the New Jersey Institute of Technology (NJIT), show how oil dilutes under specific conditions, which may lead to more effective countermeasures against large oil spills.
San Diego-based Cellics Therapeutics, which was co-founded by UC San Diego nanoengineering Professor Liangfang Zhang, has received an award of up to $15M to develop a macrophage cellular nanosponge—nanoparticles cloaked in the cell membranes of macrophages—designed to treat sepsis.
The National Academy of Medicine (NAM) has announced that University of California San Diego Professor Susan Ackerman, a pioneer in the study of homeostasis in developing and aging neurons, has been elected to membership in the prestigious organization.
Treatment with a peptide that mimics the naturally occurring protein GIV prevents immune overreaction and supports a mechanism critical for survival in mouse models of sepsis and colitis, according to a UC San Diego study.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
